Category Specific RSS

pharmaxis

Pharmaxis progresses FDA discussions, set to expand bone marrow cancer trial to treat more patients

A large cohort of patients around the world diagnosed with myelofibrosis (aka bone marrow cancer) will soon be able to…

2 years ago

German researchers publish ‘best ever’ results for urgently needed blood cancer treatment

There is an urgent need for better treatment for myelodysplastic syndrome (MDS), a type of blood cancer, and new research…

2 years ago

Aussie cancer researcher primed for 2023 with groundbreaking clinical trial data releases scheduled

Aussies are some of the most enthusiastic adopters of new clinical drugs. In 2019, 95,000 of us participated in nearly…

2 years ago

Pharmaxis cancer drug progress detailed at leading scientific conference, eyes FDA discussions in 2023

Having delivered impressive interim trial data from their Phase 2 clinical trials for a treatment targeting incurable bone marrow cancer,…

3 years ago